OCCUPATIONAL HEALTH & REHABILITATION INC
10-Q, 2000-05-15
PHARMACEUTICAL PREPARATIONS
Previous: GLOBAL OPPORTUNITY FUND LP, 10-Q, 2000-05-15
Next: SAMBA CAPITAL MANAGEMENT INTERNATIONAL LTD, 13F-NT, 2000-05-15



<PAGE>

===============================================================================

                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                   FORM 10-Q



           [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d)
               OF THE SECURITIES EXCHANGE ACT OF 1934

             For the quarterly period ended:       March 31, 2000

                                      OR

           [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)
               OF THE SECURITIES EXCHANGE ACT OF 1934


           For the transition period from ____________ to __________


                            COMMISSION FILE NUMBER:
                                    0-21428

                   OCCUPATIONAL HEALTH + REHABILITATION INC
            (Exact name of registrant as specified in its charter)


          DELAWARE                                        13-3464527
(State or other jurisdiction of             (I.R.S. Employer Identification No.)
incorporation or organization)

      175 DERBY STREET, SUITE 36
        HINGHAM, MASSACHUSETTS                            02043
(Address of principal executive offices)                (Zip code)

                                 (781) 741-5175
              (Registrant's telephone number, including area code)


    Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                     [X]  YES       [ ]  NO

     The number of shares outstanding of the registrant's Common Stock as of May
5, 2000 was 1,479,510.

===============================================================================
<PAGE>

                   OCCUPATIONAL HEALTH + REHABILITATION INC

                         QUARTERLY REPORT ON FORM 10-Q

                      FOR THE QUARTER ENDED MARCH 31, 2000

                               TABLE OF CONTENTS
                        PART I --- FINANCIAL INFORMATION

                                                                       PAGE NO.
                                                                       --------
Item 1. Financial Statements

           Consolidated Balance Sheets................................        3

           Consolidated Statements of Operations......................        4

           Consolidated Statements of Cash Flows......................        5

           Notes to Consolidated Financial Statements.................        6

Item 2. Management's Discussion and Analysis of
        Financial Condition and Results of Operations.................        7

Item 3. Quantitative and Qualitative Disclosures About Market Risk....       12

                          PART II - OTHER INFORMATION

Item 6. Exhibits and Reports on Form 8-K..............................       12

Signatures............................................................       13

Exhibit Index.........................................................       14


                                       2
<PAGE>

                         PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

                    OCCUPATIONAL HEALTH + REHABILITATION INC

                          CONSOLIDATED BALANCE SHEETS

                      (In thousands, except share amounts)


<TABLE>
<CAPTION>
                                                                     MARCH 31,              DECEMBER 31,
ASSETS                                                                 2000                     1999
                                                                    (Unaudited)
                                                               ------------------      --------------------
<S>                                                             <C>                      <C>
Current assets:
    Cash and cash equivalents.................................            $  1,210                 $  1,512
    Accounts receivable,  net.................................               7,806                    7,105
    Prepaid expenses and other assets.........................                 610                      638
                                                                     -------------              -----------
Total current assets                                                         9,626                    9,255

Property and equipment, net...................................               2,322                    2,383
Goodwill, net.................................................               5,277                    5,346
Other assets..................................................                 169                      176
                                                                     -------------              -----------
    Total assets..............................................            $ 17,394                 $ 17,160
                                                                     =============              ===========

LIABILITIES, REDEEMABLE STOCK AND STOCKHOLDERS' DEFICIT

Current liabilities:
    Accounts payable..........................................            $    705                 $    748
    Accrued expenses..........................................               2,056                    2,755
    Accrued payroll...........................................               2,173                    1,559
    Restructuring liability...................................                 347                      536
    Dividends payable.........................................                 283                      113
    Current portion of long-term debt.........................                 595                      573
    Current portion of obligations under capital leases.......                 259                      281
                                                                     -------------              -----------
Total current liabilities.....................................               6,418                    6,565

Restructuring liability.......................................                 329                      358
Long-term debt, less current maturities.......................               3,345                    2,586
Obligations under capital leases..............................                 262                      320
                                                                     -------------              -----------
Total liabilities.............................................              10,354                    9,829

Minority interest.............................................               1,162                    1,291
Redeemable stock:
    Redeemable, convertible preferred stock, Series A, $.001                 8,474                    8,470
      par value ---
Stockholders' deficit:
    Preferred stock, $.001 par value - 3,333,333 shares
      authorized; none issued and outstanding.................
    Common stock, $.001 par value -- 10,000,000 shares
      authorized; 1,580,012 shares issued in 2000 and 1999;
      and 1,479,510 shares outstanding in 2000 and 1999.......                   1                        1
    Additional paid-in capital................................              10,620                   10,620
    Accumulated deficit.......................................             (12,717)                 (12,551)
    Less treasury stock, at cost, 100,502 shares..............                (500)                    (500)
                                                                     -------------              -----------
    Total stockholders' equity deficit........................            $ (2,596)                $ (2,430)
                                                                     -------------              -----------
    Total liabilities, redeemable stock and stockholders'
       deficit................................................            $ 17,394                 $ 17,160
                                                                     =============              ===========
</TABLE>

                             See Accompanying Notes

                                       3
<PAGE>

                    OCCUPATIONAL HEALTH + REHABILITATION INC

                     CONSOLIDATED STATEMENTS OF OPERATIONS

            (In thousands, except share amounts and per share data)

                                  (Unaudited)

<TABLE>
<CAPTION>
                                                         THREE MONTHS ENDED
                                                              MARCH 31,
                                                       -----------------------
                                                          2000         1999
                                                       ----------   ----------
<S>                                                    <C>           <C>
Revenue............................................... $    9,041   $    7,014

Expenses:
  Operating...........................................      7,449        5,881
  General and administrative..........................      1,153          866
  Depreciation and amortization.......................        254          234
                                                       ----------   ----------
                                                            8,856        6,981
                                                       ----------   ----------
                                                              185           33

Nonoperating gains (losses):
  Interest income.....................................          6           19
  Interest expense....................................        (91)         (47)
  Minority interest in net profit of subsidiaries.....        (92)        (147)
                                                       ----------   ----------

Income/(loss) before income taxes.....................          8         (142)
Income taxes..........................................         --           --
                                                       ----------   ----------

Net income (loss)..................................... $        8   $     (142)
                                                       ==========   ==========

Net loss available to common shareholders............. $     (166)  $     (146)
                                                       ==========   ==========

Per share amounts:

Net loss per common share - basic..................... $    (0.11)  $    (0.10)
                                                       ==========   ==========

Weighted average common shares........................  1,479,510    1,479,444
                                                       ==========   ==========
</TABLE>



                             See Accompanying Notes

                                       4
<PAGE>

                    OCCUPATIONAL HEALTH + REHABILITATION INC

                     CONSOLIDATED STATEMENTS OF CASH FLOWS

                           (Unaudited, in thousands)
<TABLE>
<CAPTION>

                                                                                      THREE MONTHS ENDED
                                                                                          MARCH 31,
                                                                                      ------------------
                                                                                        2000       1999
                                                                                        ----       ----
<S>                                                                                    <C>        <C>
OPERATING ACTIVITIES:
Net income (loss)....................................................................  $    8      $ (142)
Adjustments to reconcile net income (loss) to net cash used in operating activities
 net of assets acquired through acquisitions or business combinations:
  Depreciation.......................................................................     177         155
  Amortization.......................................................................      77          79
  Minority interest in net profit of subsidiaries....................................      92         147
  Changes in operating assets and liabilities:
   Accounts receivable...............................................................    (701)       (961)
   Prepaid expenses and other current assets.........................................      28         148
   Notes receivable..................................................................                  57
   Restructuring liability...........................................................    (218)         --
   Accounts payable and accrued expenses
    and other long-term liabilities..................................................     (37)        324
                                                                                       ------      ------
Net cash used by operating activities................................................    (574)       (193)

INVESTING ACTIVITIES:
Cash paid to joint venture partners relating to distributions........................    (221)       (240)
Property and equipment additions.....................................................     (66)       (209)
Cash paid for acquisitions...........................................................     (42)       (463)
                                                                                       ------      ------
Net cash used by investing activities................................................    (329)       (912)

FINANCING ACTIVITIES:
Payments of long-term debt...........................................................    (119)        (62)
Payments on capital lease obligations................................................     (80)        (49)
Proceeds from lines of credit and loans payable......................................     800         729
                                                                                       ------      ------
Net cash provided by financing activities............................................     601         618
                                                                                       ------      ------
Net decrease in cash and cash equivalents............................................    (302)       (487)
Cash and cash equivalents at beginning of period.....................................   1,512       1,562
                                                                                       ------      ------
Cash and cash equivalents at end of period...........................................  $1,210      $1,075
                                                                                       ======      ======
</TABLE>
                             See Accompanying Notes

                                       5
<PAGE>

                    OCCUPATIONAL HEALTH + REHABILITATION INC

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                    (Unaudited, dollar amounts in thousands)


 1.   BASIS OF PRESENTATION

   The accompanying unaudited interim financial statements of Occupational
 Health + Rehabilitation Inc (the "Company") have been prepared in accordance
 with the instructions to Form 10-Q and Rule 10.01 of Regulation S-X pertaining
 to interim financial information and disclosures required by generally accepted
 accounting principles.  The interim financial statements presented herein
 reflect all adjustments (consisting of normal recurring adjustments) which, in
 the opinion of management, are considered necessary for a fair presentation of
 the Company's financial condition as of March 31, 2000 and results of
 operations for the three months ended March 31, 2000 and 1999.  The results of
 operations for the three months ended March 31, 2000 are not necessarily
 indicative of the results that may be expected for a full year.

 2.  NET INCOME (LOSS) PER COMMON SHARE

   The Company calculates earnings per share in accordance with SFAS No. 128,
 Earnings per Share, which requires disclosure of basic and diluted earnings per
 share.  Basic earnings per share excludes any dilutive effects of options,
 warrants and convertible securities while diluted earnings per share includes
 such amounts.

 3.  EARNINGS PER SHARE

       The following table sets forth the computation of basic and diluted
earnings per share (amounts in thousands, except share and per share data):

<TABLE>
<CAPTION>
                                                                                               THREE MONTHS ENDED
                                                                                                    MARCH 31,
                                                                                   -----------------------------------
                                                                                         2000                1999
                                                                                   ---------------       -------------
<S>                                                                                  <C>                   <C>
LOSS
Net income (loss).............................................................          $        8          $     (142)
Dividends accrued.............................................................                (170)                 --
Accretion on preferred stock redemption value.................................                  (4)                 (4)
                                                                                   ---------------       -------------
Loss available to common stockholders.........................................          $     (166)         $     (146)
                                                                                   ===============       =============
SHARES
Total weighted average shares outstanding (basic and diluted).................           1,479,510           1,479,444
                                                                                   ===============       =============

Net loss available to common shareholders.....................................          $    (0.11)         $    (0.10)
                                                                                   ===============       =============
</TABLE>

Notes: The effect of options, convertible preferred stock and a convertible note
       payable is not considered as it would be antidilutive for the periods
       presented.

4. JOINT VENTURES

   During the first quarter of 2000, the Company entered into a joint venture
 with SSM Healthcare System to own and operate six occupational health centers
 in St. Louis, Missouri.  The Company holds an 80% interest in the joint
 venture.  The Company also has a management contract with the joint venture for
 an initial term of twenty years with automatic renewals for successive five-
 year terms.

                                       6
<PAGE>

 ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATIONS


 OVERVIEW

    The Company is a leading provider of occupational health care services to
 employers and their employees specializing in the prevention, treatment and
 management of work related injuries and illnesses.  The Company develops and
 operates multidisciplinary, outpatient healthcare centers and contracts with
 other health care providers to develop integrated occupational health care
 delivery systems. The Company typically operates the centers under management
 and submanagement agreements with professional corporations that practice
 exclusively through such centers.  Additionally, the Company has entered into
 joint ventures with health systems to provide management and related services
 to the centers and networks of providers established by the joint ventures.

    The following table sets forth, for the periods indicated, the relative
 percentages which certain items in the Company's consolidated statements of
 operations bear to  revenue. The following information should be read in
 conjunction with the consolidated financial statements and notes thereto
 included elsewhere in this report. Historical results and percentage
 relationships are not necessarily indicative of the results that may be
 expected for any future period.

<TABLE>
<CAPTION>
                                                         THREE MONTHS ENDED
                                                             MARCH 31,
                                                 -------------------------------
                                                         2000            1999
                                                 ------------     -----------
<S>                                               <C>             <C>
Revenue..........................................         100%            100%
Operating expenses...............................         (82)            (84)
General and administrative expenses..............         (13)            (12)
Depreciation and amortization expense............          (3)             (3)
Interest expense.................................          (1)             (1)
Minority interest in net profit of subsidiaries..          (1)             (2)
                                                 ------------     -----------
Net loss.........................................           0%             (2%)
                                                 ============     ===========
</TABLE>


                                       7
<PAGE>

 RESULTS OF OPERATIONS (DOLLAR AMOUNTS IN THOUSANDS)
 ---------------------

 THREE MONTHS ENDED MARCH 31, 2000 AND 1999
 ------------------------------------------

 Revenue

   Revenue increased 29% to approximately $9,041 in the three months ended March
 31, 2000 from approximately $7,014 in the three months ended March 31, 1999.
 Of the approximately $2,027 increase in revenue in the three months ended March
 31, 2000 and compared to the three months ended March 31, 1999, approximately
 $1,969 related to centers acquired subsequent to March 31, 2000 and
 approximately $790 related to additional volume at existing centers.  These
 increases were partially offset by the elimination of $732 of revenue generated
 in the prior year by centers closed during the fourth quarter of 1999.

 Operating, General, and Administrative Expenses

   Operating expenses increased 27% to approximately $7,449  in the three months
 ended March 31, 2000 from approximately $5,881 in the three months ended March
 31, 1999.  This increase was principally due to the acquisition and management
 of additional centers.  As a percentage of revenue, operating expenses declined
 to 82% in the three months ended March 31, 2000 from 84% in the three months
 ended March 31, 1999.  The decrease primarily relates to the closure of several
 underperforming centers in  the fourth quarter of 1999. The centers, in the
 aggregate, improved their profitability before general  and administrative
 expenses during the first quarter of 2000 with center operating profit rising
 to 18% of revenue in 2000 from 16% in 1999.

   General and administrative expenses increased 33% to approximately $1,153 in
 the three months ended March 31, 2000 from $866  in the three months ended
 March 31, 1999.  The increase primarily resulted from adding resources in
 information services, accounting, and medical oversight. As a percentage of
 revenue, general and administrative expenses approximated 13% in the three
 months ended March 31, 2000 compared to 12% in the three months ended March 31,
 1999.

 Depreciation and Amortization

   Depreciation and amortization expense increased 9% to approximately $254 in
 the three months ended March 31, 2000 from approximately $234 in the three
 months ended March 31, 1999.  The increase occurred primarily as a result of
 additional growth through acquisitions as well as capital expenditures
 principally  for information systems infrastructure.  As a percentage of
 revenue, depreciation and amortization was 3% for both the three months ended
 March 31, 2000 and 1999.

 Minority Interest

   Minority interest represents the share of profits of minority investors in
 certain joint ventures with the Company.  In the three months ended March 31,
 2000, the minority interest in net profits of subsidiaries was $92 compared to
 $147 in the three months ended March 31, 1999.

                                       8
<PAGE>

 Restructuring Charge

   During the fourth quarter of 1999, the Company adopted, communicated and
 implemented a restructuring plan to close certain centers that were either
 outside of the Company's core occupational health focus or were deemed not
 capable of achieving significant profitability due to specific market factors.
 As a result of the restructuring plan and other actions, the Company recorded a
 charge of $2,262 during the fourth quarter of 1999.  Further, the restructuring
 plan included the streamlining of certain other remaining operations and the
 elimination or combining of various other positions within the Company.  The
 initial charge recognized and the status of the accrued liabilities is as
 follows:

<TABLE>
<CAPTION>
                                                    DECEMBER 31, 1999          MARCH 31, 2000
                                         --------------------------------    -------------------
                                                                                         ENDING
                                         INITIAL                                         ACCRUAL
DESCRIPTION                               CHARGE      PAYMENT    ACCRUALS    PAYMENT     BALANCE
- -----------                              -------      -------    --------    -------     -------
<S>                                        <C>         <C>          <C>       <C>         <C>
ACCRUED LIABILITIES
 Severance costs                           $  151        $8         $143        $110       $ 33
 Lease Abandonment Costs                      683        --          683          70        613
 Miscellaneous                                 68        --           68          38         30
                                                                    ----        ----       ----
                                                                    $894        $218       $676
                                                                    ====        ====       ====

ASSET IMPAIRMENTS
 Fixed Asset Writedowns and Disposals         319
 Goodwill Impairment                          340
 Receivable Writedown                         690
 Miscellaneous                                 11
                                           ------
                                           $2,262
                                           ======
</TABLE>

 Seasonality

   The Company is subject to the natural seasonal swing that impacts the various
 employers and employees it serves.  Although the Company hopes that as it
 continues its growth and development efforts it may be able to anticipate the
 effect of these swings and provide services aimed to ameliorate this impact,
 there can be no assurance that it can completely alleviate the effects of
 seasonality.   Historically, the Company has noticed these impacts  in portions
 of the first and fourth quarters.  Traditionally, revenues are lower during
 these periods since patient visits decrease due to the occurrence of plant
 closings, vacations, holidays, a reduction in new employee hiring and the
 impact of severe weather conditions in the Northeast.  These activities also
 cause a decrease in drug and alcohol testing, medical monitoring services and
 pre-employment examinations. The Company has also noticed similar impacts
 during the summer months, but typically to a lesser degree than during the
 first and fourth quarters.

 LIQUIDITY AND CAPITAL RESOURCES

   Since inception, the Company's funding requirements have been met through a
 combination of issuances of capital stock, long-term debt and other
 commitments, and the utilization of capital lease borrowings and loans to
 finance equipment purchases. The Company has utilized its funds in its
 expansion effort and for working capital. At March 31, 2000, the Company had
 $3,208 in working capital, an increase of  $518 from December 31, 1999.  The
 Company's principal sources of liquidity as of March 31, 2000 consisted of (i)
 cash and cash equivalents aggregating approximately $1,210, (ii) current
 accounts receivable of approximately $7,806, and (iii) combined debt credit
 facility availability of $4,207.

                                       9
<PAGE>

 LIQUIDITY AND CAPITAL RESOURCES (continued)

   Net cash used by operating activities of the Company during the three months
 ended March 31, 2000 was approximately $574 as compared to approximately $193
 for the three months ended March 31, 1999.  During these periods, the primary
 uses of cash were the funding of working capital in centers in early stages of
 development or centers that were recently acquired and the payment of
 restructuring liabilities.

   Net cash used by investing activities for the three months ended March 31,
 2000 and 1999 was approximately $329 and $912, respectively.  Amounts involved
 in investing activities included the use of $66 and $209 for fixed asset
 additions in the three  months ended March 31, 2000 and 1999, respectively.
 Fixed asset additions for the three months ended March 31, 2000 related
 primarily to computer hardware and software.

   For the three months ended March 31, 2000, the Company paid $42 relating to
 earnouts on previously acquired businesses.  Additionally, effective March 31,
 2000, the Company entered into a joint venture with SSM Healthcare System to
 own and operate six occupational health centers in St. Louis, Missouri. The
 first installment payment on this purchase was paid during the second quarter
 of 2000.

   During the three months ended March 31, 2000, the Company also paid cash of
 $221 relating to distributions to its joint venture partners as compared to
 $240 for the prior year's quarter. Distributions of joint venture subsidiary
 cash to the Company and its joint venture partners allow the Company access to
 its share of the cash for general corporate purposes. The Company expects to
 continue to make distributions depending upon the cash balances in the joint
 venture cash accounts.

   Net cash provided by financing activities was $601 and $618 for the three
 months ended March 31, 2000 and 1999, respectively.  The Company used funds of
 approximately $199 and $111 in 2000 and 1999, respectively, for the payment of
 long-term debt and other current obligations.  For the three months ended March
 31, 2000, the Company received proceeds from its line of credit of $800.
 These funds were utilized to fund first quarter 2000 working capital needs.
 For the quarter ended March 31, 1999, the Company received proceeds of $729
 from its line of credit and a Master Lease Agreement in effect at the time.

   The Company expects that its principal use of funds in the near future will
 be in connection with acquisitions and the formation of joint venture entities
 and provider networks, working capital requirements, debt repayments and
 purchases of property and equipment and the payment of accrued dividends on the
 Company's Series A Convertible Preferred Stock, when and if declared payable by
 the Board of Directors. After November 5, 1999, such dividends accrue at an
 annual cumulative rate of $0.48 per share, subject to certain adjustments.

   During November 1997, the Company entered into a financing arrangement with
 Fleet National Bank (f/k/a BankBoston, N.A.) whereby it had access to two
 separate credit facilities.  The first credit facility provides the Company the
 ability to borrow $5,000 for working capital and acquisition needs.  The second
 facility provides the ability to borrow up to $2,000 to be utilized by the
 Company's existing and future joint ventures (the "JV Line").   The borrowing
 base for the JV Line is eighty-five percent (85%) of the joint ventures'
 accounts receivable less than 120 days old. The credit facilities expire on
 June 30, 2001 and are subject to loan covenants.  The credit facilities had an
 outstanding balance of $2,793 as of March 31, 2000.

                                       10
<PAGE>

 LIQUIDITY AND CAPITAL RESOURCES (continued)

   The Company expects that the cash received as a result of the previously
 mentioned credit facilities and line, and cash generated from operations will
 be adequate through June 30, 2001 to provide working capital, fund debt
 repayments, to finance any necessary capital expenditures, and to fund the
 above referenced dividend payments, if any, through June 30, 2001.  However,
 the Company believes that the level of financial resources available to it is
 an important competitive factor and expects to seek refinancing opportunities,
 as well as further financings during the 2000 fiscal year in anticipation of
 the maturity of the credit facilities in 2001 and the Company's projected
 future needs during subsequent fiscal years.   The Company will also consider
 raising additional equity capital on an on-going basis as market factors and
 its needs suggest, since additional resources may be necessary to fund
 acquisitions by the Company.

 INFLATION

    The Company does not believe that inflation had a significant impact on its
 results of operations during the last three years. Further, inflation is not
 expected to adversely affect the Company in the future unless it increases
 substantially, and the Company is unable to pass through the increases in its
 billings and collections.

 IMPORTANT FACTORS REGARDING FORWARD-LOOKING STATEMENTS

    Statements contained in this Quarterly Report on Form 10-Q, including in
 "Management's Discussion and Analysis of Financial Condition and Results of
 Operations," contain forward-looking statements within the meaning of Section
 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange
 Act of 1934, which statements are intended to be subject to the "safe-harbor"
 provisions of the Private Securities Litigation Reform Act of 1995.  The
 forward-looking statements are based on management's current expectations and
 are subject to many risks and uncertainties, which could cause actual results
 to differ materially from such statements.  Such statements include statements
 regarding the Company's objective to develop a comprehensive regional network
 of occupational healthcare centers providing integrated services through multi-
 disciplinary teams.  In addition, when used in this report, the words
 "anticipate," "plan," "believe," "estimate,"  "expect" and similar expressions
 as they relate to the Company or its management, are intended to identify
 forward-looking statements.  Among the risks and uncertainties that may affect
 the Company's actual results are locating and identifying suitable acquisition
 candidates, the ability to consummate acquisitions on favorable terms, the
 success of such acquisitions, if completed, the cost and delays inherent in
 managing growth, the ability to attract and retain qualified professionals and
 other employees to expand and complement the Company's services, the
 availability of sufficient financing and the attractiveness of the Company's
 capital stock to finance acquisitions and working capital needs, strategies
 pursued by competitors, the restrictions imposed by government regulation,
 changes in the industry resulting from changes in workers' compensation laws,
 regulations and in the healthcare environment generally, and other risks
 described in this Quarterly Report on Form 10-Q and the Company's other filings
 with the Securities and Exchange Commission.

                                       11
<PAGE>

 ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

          Not applicable.




                          PART II - OTHER INFORMATION
                          ---------------------------


 ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

         a.  Exhibits
             27.01 Financial Data Schedule*
    *Filed herewith
         b.  Reports on Form 8-K
             None.

                                       12
<PAGE>

                                   SIGNATURES


    Pursuant to the requirements of the Securities Exchange Act of 1934, the
 registrant has duly caused this report to be signed on its behalf by the
 undersigned thereunto duly authorized.



OCCUPATIONAL HEALTH + REHABILITATION INC


By:        /s/ John C. Garbarino
    ------------------------------------------------------
    John C. Garbarino
    President, Chief Executive Officer and Chief Financial Officer



By:     /s/ Janice M. Goguen
    ---------------------------------------------------
    Janice M. Goguen
    Vice-President of Finance, Treasurer




Date: May 15, 2000

                                       13
<PAGE>

                                 EXHIBIT INDEX


EXHIBIT
NO.                  DESCRIPTION
- ------               -----------

27.1                 Financial Data Schedule.

                                       14

<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               MAR-31-2000             MAR-31-1999
<CASH>                                           1,210                   1,512
<SECURITIES>                                         0                       0
<RECEIVABLES>                                    8,617                   7,849
<ALLOWANCES>                                     (811)                   (744)
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                 9,626                   9,255
<PP&E>                                           4,180                   4,255
<DEPRECIATION>                                 (1,858)                 (1,872)
<TOTAL-ASSETS>                                  17,394                  17,160
<CURRENT-LIABILITIES>                            6,418                   6,565
<BONDS>                                              0                       0
                            8,474                   8,470
                                          0                       0
<COMMON>                                             1                       1
<OTHER-SE>                                     (2,597)                 (2,431)
<TOTAL-LIABILITY-AND-EQUITY>                    17,394                  17,160
<SALES>                                          9,041                   7,014
<TOTAL-REVENUES>                                 9,041                   7,014
<CGS>                                                0                       0
<TOTAL-COSTS>                                    8,856                   6,981
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                  91                      47
<INCOME-PRETAX>                                      8                   (142)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                         8                   (142)
<EPS-BASIC>                                     (0.11)                  (0.10)
<EPS-DILUTED>                                   (0.11)                  (0.10)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission